Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in TaxesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Cash from Operations (2022 - 2025)

Historic Cash from Operations for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$10.6 million.

  • InflaRx's Cash from Operations rose 37.49% to -$10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.6 million, marking a year-over-year increase of 962.04%. This contributed to the annual value of -$52.6 million for FY2024, which is 2917.64% down from last year.
  • As of Q3 2025, InflaRx's Cash from Operations stood at -$10.6 million, which was up 37.49% from -$8.5 million recorded in Q2 2025.
  • InflaRx's 5-year Cash from Operations high stood at -$3.2 million for Q3 2022, and its period low was -$16.2 million during Q1 2024.
  • For the 4-year period, InflaRx's Cash from Operations averaged around -$10.9 million, with its median value being -$11.7 million (2023).
  • Per our database at Business Quant, InflaRx's Cash from Operations crashed by 11984.09% in 2023 and then skyrocketed by 3457.08% in 2025.
  • InflaRx's Cash from Operations (Quarter) stood at -$5.3 million in 2022, then plummeted by 119.84% to -$11.7 million in 2023, then decreased by 8.63% to -$12.7 million in 2024, then increased by 16.86% to -$10.6 million in 2025.
  • Its Cash from Operations was -$10.6 million in Q3 2025, compared to -$8.5 million in Q2 2025 and -$14.7 million in Q1 2025.